Japan's Sumitomo merges oncology arms Tolero Pharma, Boston Biomedical

Japan's Sumitomo merges oncology arms Tolero Pharma, Boston Biomedical

Medical drugs in a pharmacy. Credit: Flickr/epSos .de

Sumitomo Dainippon Pharma (SDP) has merged two of its US-based wholly owned subsidiaries, Tolero Pharmaceuticals and Boston Biomedical, to form Sumitomo Dainippon Pharma Oncology, the company said in a statement Wednesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter